Weber’s syndrome, also known as superior alternating hemiplegia or midbrain stroke syndrome, is a neurological condition caused by damage to the ventral portion of the midbrain. In this syndrome, a lesion—most often an infarction—involves the oculomotor (third cranial) nerve fascicles as they pass through the interpeduncular cistern, as well as the adjacent corticospinal tract within the cerebral peduncle. As a result, patients present with an ipsilateral oculomotor nerve palsy (drooping eyelid, “down and out” eye position, dilated pupil) together with contralateral hemiparesis or hemiplegia of the body en.wikipedia.org.
Weber’s syndrome, also known as “midbrain stroke syndrome” or “superior alternating hemiplegia,” is a rare neurological condition caused by an infarction (stroke) in the medial part of the midbrain. This area contains both the oculomotor nerve fascicles (which control most eye movements and eyelid elevation) and the descending corticospinal fibers (which carry motor signals from the brain to the opposite side of the body). When a small arterial branch—most often from the posterior cerebral artery—becomes occluded, it damages these structures. The result is an ipsilateral (same-side) oculomotor nerve palsy (drooping eyelid, “down-and-out” eye position, and pupil dilation) alongside contralateral (opposite-side) weakness or paralysis of the arm and leg. en.wikipedia.org ncbi.nlm.nih.gov
Pathophysiology
In Weber’s syndrome, the infarct typically involves the cerebral peduncle (where corticospinal and corticobulbar fibers run) and the oculomotor nerve fibers as they exit the midbrain. Damage to the oculomotor nerve fibers produces an ipsilateral lower-motor-neuron–type oculomotor palsy: ptosis (eyelid droop), mydriasis (dilated pupil), and an eye that rests “down and out.” Injury to the corticospinal tract just before it crosses in the lower brainstem leads to contralateral upper-motor-neuron signs—weakness, spasticity, and increased reflexes—in the arm and leg. Patients may also have mild facial weakness or tongue deviation if corticobulbar fibers are affected en.wikipedia.org.
Weber’s syndrome typically arises from occlusion of a branch of the posterior cerebral artery—particularly its paramedian perforating branches—or less commonly from basilar artery perforators. The precise location and extent of the lesion in the midbrain determine the clinical features, but the hallmark remains the combination of an oculomotor deficit on one side and motor weakness on the other en.wikipedia.org. This alternating pattern—cranial nerve involvement on the side of the lesion, body weakness on the opposite side—reflects the crossing of the corticospinal fibers below the midbrain in the medulla.
Types of Weber’s Syndrome
Weber’s syndrome can be classified into several types based on the underlying cause or lesion characteristics:
Ischemic Weber’s Syndrome
Caused by a small-vessel or large-vessel infarction in the ventral midbrain, often due to atherosclerosis, thromboembolism, or small-vessel lipohyalinosis.Hemorrhagic Weber’s Syndrome
Results from a bleed—such as a cavernous malformation or hypertension-induced hemorrhage—within the ventral midbrain, producing a similar pattern of deficits.Neoplastic Weber’s Syndrome
Occurs when a tumor (e.g., glioma or metastasis) compresses the oculomotor fascicles and corticospinal tract in the cerebral peduncle.Demyelinating Weber’s Syndrome
Seen in diseases like multiple sclerosis where a demyelinating plaque affects the midbrain region, mimicking the vascular form.Traumatic Weber’s Syndrome
Follows direct injury to the midbrain—such as penetrating or shearing trauma—leading to focal damage of the oculomotor fibers and motor tracts.
Causes of Weber’s Syndrome
Occlusion of the Paramedian Branches of the Posterior Cerebral Artery
Most common cause—these tiny arteries supply the ventral midbrain where the oculomotor nerve and corticospinal tract lie.Basilar Artery Perforator Infarction
A blockage in perforating branches of the basilar tip can similarly compromise the ventral midbrain.Cardioembolic Stroke
A blood clot originating from the heart (e.g., atrial fibrillation) can lodge in midbrain perforators.Large-Artery Atherosclerosis
Plaque buildup in the vertebrobasilar system may narrow or block the vessels feeding the midbrain.Small-Vessel Lipohyalinosis
Chronic hypertension can lead to hyaline degeneration of small arteries, causing lacunar infarcts in the midbrain.Cavernous Malformation Hemorrhage
Rupture of a vascular malformation in the midbrain can produce a hemorrhagic Weber’s syndrome.Basilar Tip Aneurysm Rupture
Although rare, bleeding near the oculomotor fascicles can mimic the syndrome.Brainstem Tumors
Primary (e.g., glioma) or metastatic lesions may compress the involved structures.Multiple Sclerosis
Demyelinating plaques can affect the midbrain region, leading to alternating hemiplegia.Arteriovenous Malformation (AVM)
High-flow AVMs in the brainstem can disrupt normal blood supply and cause focal injury.Vasculitis
Inflammation of cerebral vessels (e.g., lupus, Behçet’s) can narrow midbrain arteries.Cerebral Vasospasm
Following subarachnoid hemorrhage, vasospasm may involve paramedian branches.Traumatic Brain Injury
Direct trauma or shearing forces can damage the midbrain’s ventral aspect.Infectious Vasculopathy
Infections (e.g., syphilis, varicella-zoster) can inflame vessels and cause infarction.Sickle Cell Crisis
Sickled cells can clog small brainstem vessels, causing infarcts.Mitochondrial Disorders
Conditions like MELAS may predispose to stroke-like episodes in the midbrain.Hypercoagulable States
Disorders such as antiphospholipid syndrome increase risk of in-situ thrombosis.Carotid or Vertebral Artery Dissection
Dissection can extend into branches that perfuse the midbrain.Hypotensive Episodes
Severe drops in blood pressure (e.g., during surgery) may cause watershed infarcts in the midbrain.Toxic-Metabolic Injury
Less common toxins or metabolic derangements (e.g., carbon monoxide, severe hypoglycemia) can selectively injure brainstem neurons.
Symptoms of Weber’s Syndrome
Ptosis (Eyelid Droop)
Weakness of the levator palpebrae superioris muscle leads to a drooping upper eyelid on the affected side.“Down and Out” Eye Position
Paralysis of most extraocular muscles—except the superior oblique and lateral rectus—causes the eyeball to rest downwards and laterally.Pupil Dilation (Mydriasis)
Damage to parasympathetic fibers of the oculomotor nerve leads to a fixed, dilated pupil on the lesioned side.Loss of Pupillary Light Reflex
The affected eye fails to constrict in response to light due to oculomotor nerve involvement.Diplopia (Double Vision)
Misalignment of the eyes from extraocular muscle paralysis produces double vision, especially on upward or medial gaze.Contralateral Hemiparesis
Weakness of arm and leg on the side opposite the lesion, reflecting corticospinal tract damage.Hyperreflexia
Increased deep tendon reflexes in the contralateral limbs due to upper motor neuron loss of inhibition.Positive Babinski Sign
Upward extension of the big toe on plantar stimulation of the contralateral foot.Contralateral Spasticity
Increased muscle tone on the body side opposite the lesion, leading to stiffness.Facial Weakness
If corticobulbar fibers are involved, some weakness of lower facial muscles contralaterally may appear.Dysarthria
Slurred speech can occur secondary to impaired bulbar function.Dysphagia
Difficulty swallowing if nearby cranial nerve fibers or corticobulbar tracts are partially affected.Ataxia
Rarely, involvement of adjacent cerebellar pathways can cause unsteadiness or incoordination.Tremor or Parkinsonism
Lesion extension into the substantia nigra may produce rigidity and tremor on the opposite side.Gaze Palsy
Inability to move both eyes in a certain direction if oculomotor subnuclei are compromised.Headache
Often sudden and severe when the cause is hemorrhagic or large infarction.Nausea and Vomiting
Common in acute brainstem lesions due to involvement of adjacent autonomic centers.Altered Level of Consciousness
Large or bilateral lesions can impair reticular activating system pathways.Anisocoria
Noticeable difference in pupil sizes, with the ipsilateral pupil larger and unreactive.Photophobia
Sensitivity to light in the affected eye due to unopposed sympathetic dilation.
Diagnostic Tests
Physical Examination
Neurological Screening
A head-to-toe assessment of mental status, cranial nerves, motor strength, coordination, and reflexes.Cranial Nerve III Testing
Assess eyelid elevation, eye movements in all directions, and pupillary responses to light.Motor Strength Grading
Manual evaluation of muscle strength in limbs using the Medical Research Council (MRC) 0–5 scale.Deep Tendon Reflexes
Testing biceps, triceps, patellar, and Achilles reflexes to identify hyperreflexia.Plantar Response (Babinski Test)
Stroking the sole to check for an extensor toe response.Muscle Tone Assessment
Passive flexion and extension of limb joints to detect spasticity.Sensory Examination
Pinprick, vibration, and proprioception tests to rule out sensory loss.Coordination Tests
Finger-to-nose and heel-to-shin maneuvers evaluate cerebellar function.Gait Observation
Watching the patient walk to identify spastic or ataxic patterns.Romberg Test
Standing with feet together, eyes closed, to assess proprioceptive stability.
Manual Tests
Forced Duction Test
Gently moving the patient’s eye with forceps to distinguish nerve palsy from mechanical restriction.Pronator Drift Test
Arms outstretched, palms up—drifting or pronation suggests corticospinal tract involvement.Oculocephalic Reflex (Doll’s Eye Maneuver)
Head rotation while observing eye movement to test brainstem integrity.Smooth Pursuit Testing
Patient follows a moving object to evaluate extraocular muscle control.Saccadic Eye Movement Test
Rapid gaze shifts between two targets check supranuclear control.Convergence Test
Bringing a target toward the nose to assess medial rectus function.Accommodation Reflex
Observing pupil constriction as the patient focuses on a near object.Nystagmus Evaluation
Detecting involuntary jerking eye movements on lateral gaze.Pinch and Grip Strength
Manual dynamometry or simple pinch/grope to quantify limb weakness.Jaw-Jerk Reflex
Light tap on the chin with mouth slightly open to test corticobulbar involvement.
Lab and Pathological Tests
Complete Blood Count (CBC)
Checks for anemia, infection, or platelet disorders.Basic Metabolic Panel (BMP)
Evaluates electrolytes and kidney function to rule out metabolic causes.Coagulation Profile (PT/aPTT/INR)
Screens for bleeding or clotting disorders that could cause stroke.Lipid Profile
Assesses cholesterol levels for atherosclerotic risk.Erythrocyte Sedimentation Rate (ESR) & C-Reactive Protein (CRP)
Markers of systemic inflammation (e.g., vasculitis).Thrombophilia Screen
Tests for antiphospholipid antibodies, protein C/S deficiency, factor V Leiden.Syphilis Serology (VDRL/RPR)
Detects neurosyphilis, which can cause vasculitic infarcts.HIV Test
Identifies immunodeficiency states that predispose to infection or vasculitis.Blood Cultures
If infectious endocarditis or septic emboli are suspected.Lumbar Puncture (CSF Analysis)
Examines cells and protein for infectious or inflammatory processes.
Electrodiagnostic Tests
Electroencephalography (EEG)
Rules out seizures or subclinical cortical irritability.Electromyography (EMG)
Evaluates muscle activation patterns, helping distinguish central vs peripheral causes.Nerve Conduction Studies (NCS)
Measures peripheral nerve function to exclude neuropathy.Visual Evoked Potentials (VEP)
Tests optic pathway integrity, which can be affected in demyelinating lesions.Brainstem Auditory Evoked Response (BAER)
Checks conduction through the brainstem auditory pathways.
Imaging Tests
Non-Contrast CT Scan of the Head
Quick screening for hemorrhage or large infarcts in emergency settings.Magnetic Resonance Imaging (MRI) of the Brain
High-resolution images—particularly diffusion-weighted imaging—detect acute infarction in the midbrain.Magnetic Resonance Angiography (MRA)
Visualizes blood vessels to identify occlusions or stenoses in the posterior circulation.CT Angiography (CTA)
Rapid assessment of vascular anatomy and identification of embolic sources.Digital Subtraction Angiography (DSA)
The gold standard for detailed vessel imaging, used when endovascular intervention is planned.
Non-Pharmacological Treatments
A. Physiotherapy and Electrotherapy Therapies
Neuromuscular Re-education
Description: Task-oriented drills to retrain precise eye and limb movements.
Purpose: Improve coordination between ocular muscles and contralateral limbs.
Mechanism: Repetitive, targeted practice enhances neuroplastic changes in spared neural circuits.
Balance and Gait Training
Description: Walking exercises on parallel bars or treadmill with harness.
Purpose: Restore safer, more symmetric walking patterns.
Mechanism: Provides sensory feedback that recalibrates motor control networks.
Mirror Therapy
Description: The patient observes a mirror image of the unaffected limb moving normally.
Purpose: Decrease learned nonuse and improve motor output on the weak side.
Mechanism: Visual input drives mirror neuron systems to enhance motor cortex excitability.
Functional Electrical Stimulation (FES)
Description: Surface electrodes deliver low-level currents to paretic limb muscles.
Purpose: Strengthen weak muscles and improve voluntary activation.
Mechanism: Electrical pulses depolarize motor units, facilitating muscle contraction and re-education.
Transcranial Direct Current Stimulation (tDCS)
Description: Mild electrical current applied via scalp electrodes over the motor cortex.
Purpose: Prime neural circuits to respond better to therapy.
Mechanism: Modulates cortical excitability, boosting long-term potentiation processes.
Robot-Assisted Therapy
Description: Exoskeleton or end-effector devices guide the affected limb through movements.
Purpose: Provide high-repetition, reproducible practice.
Mechanism: Motors assist or resist movement, promoting motor learning and strength gains.
Constraint-Induced Movement Therapy (CIMT)
Description: The unaffected limb is restrained, forcing use of the weaker side.
Purpose: Overcome “learned nonuse” of the paretic limb.
Mechanism: High-intensity use drives cortical reorganization favoring the affected side.
Biofeedback Training
Description: Visual or auditory feedback on muscle activation patterns.
Purpose: Increase patient awareness and control of weakened muscles.
Mechanism: Immediate feedback reinforces correct motor recruitment patterns.
Proprioceptive Neuromuscular Facilitation (PNF)
Description: Diagonal, rotational movement patterns guided by the therapist.
Purpose: Improve strength and range of motion through functional movement patterns.
Mechanism: Stimulates proprioceptors, enhancing coordinated recruitment of multiple muscles.
Hydrotherapy
Description: Aquatic exercises in a warm pool setting.
Purpose: Reduce weight bearing on affected limbs to facilitate movement.
Mechanism: Buoyancy relieves stress on joints and muscles, allowing more fluid motion.
Serial Casting
Description: Gradual repositioning of a joint in a cast to reduce spasticity.
Purpose: Increase passive range of motion in spastic joints.
Mechanism: Sustained stretch alters muscle-tendon unit length and reflex excitability.
Soft Tissue Mobilization
Description: Hands-on techniques to loosen tight muscles and fascia.
Purpose: Decrease stiffness and pain, improving comfort during movement.
Mechanism: Mechanical forces transiently reduce fascial adhesions and stimulate blood flow.
Electrical Muscle Stimulation for Spasticity
Description: Reciprocal stimulation of antagonistic muscle groups.
Purpose: Decrease hypertonicity through reciprocal inhibition.
Mechanism: Activating the antagonist induces spinal interneurons to inhibit spastic muscles.
Transcutaneous Electrical Nerve Stimulation (TENS)
Description: Surface electrodes deliver painless currents to reduce pain.
Purpose: Improve participation in rehabilitation by reducing discomfort.
Mechanism: Activates large-diameter afferents that inhibit pain pathways at the spinal level.
Vestibular Rehabilitation
Description: Head-eye coordination and balance exercises.
Purpose: Address dizziness or balance issues from midbrain involvement.
Mechanism: Habituation and adaptation exercises recalibrate vestibulo-ocular reflexes.
B. Exercise Therapies
Aerobic Endurance Training
Build cardiovascular fitness through walking, cycling, or arm ergometry.
Resistance Band Workouts
Strengthen upper and lower limbs safely, progressing resistance gradually.
Seated Core-Stability Drills
Improve trunk control, essential for stable limb movements.
Tai Chi Movements
Gentle weight-shifting exercises enhance balance and proprioception.
Whole-Body Vibration
Standing on a vibrating platform to elicit reflexive muscle contractions.
Recumbent Stepper Sessions
Combine arm and leg cycling to boost strength and coordination.
Pilates-Based Mat Work
Focused on controlled core and limb movements to enhance motor control.
Obstacle-Course Progression
Graduated stepping and reaching tasks to challenge dynamic balance.
C. Mind-Body Therapies
Guided Imagery
Visualization of moving the affected eye and limb to recruit neural networks.
Meditation for Stress Reduction
Mindfulness practices lower cortisol, facilitating neuroplasticity.
Yoga Postural Sequences
Gentle poses integrate breath control with slow movements.
Relaxation Breathing Exercises
Diaphragmatic breathing reduces sympathetic overactivity, improving muscle tone.
D. Educational Self-Management
Stroke Education Workshops
Teach patients and families about recognizing symptoms and preventing recurrence.
Home-Exercise Program Training
Customized daily routines to maintain gains between therapy sessions.
Goal-Setting and Problem-Solving Skills Training
Empower patients to set realistic milestones and adapt strategies when barriers arise.
Pharmacological Treatments (Drugs)
Alteplase (tPA)
Class: Thrombolytic
Dosage: 0.9 mg/kg IV (max 90 mg), 10% as bolus, remainder over 60 min
Timing: Within 4.5 hours of symptom onset
Side Effects: Intracranial hemorrhage, angioedema
Tenecteplase
Class: Thrombolytic
Dosage: 0.25 mg/kg IV bolus
Timing: Within 4.5 hours
Side Effects: Bleeding, allergic reactions
Aspirin
Class: Antiplatelet
Dosage: 160–325 mg daily
Timing: Start within 24–48 hours of stroke
Side Effects: Gastric irritation, bleeding
Clopidogrel
Class: P2Y₁₂ inhibitor
Dosage: 75 mg daily
Timing: For secondary prevention
Side Effects: Bruising, diarrhea
Dipyridamole + Aspirin
Class: PDE inhibitor + antiplatelet
Dosage: 200 mg dipyridamole ER + 25 mg aspirin twice daily
Timing: Secondary prevention
Side Effects: Headache, gastrointestinal upset
Warfarin
Class: Vitamin K antagonist
Dosage: Adjust to INR 2.0–3.0
Timing: Atrial fibrillation or cardioembolic source
Side Effects: Bleeding, skin necrosis
Apixaban
Class: Direct oral anticoagulant (DOAC)
Dosage: 5 mg twice daily
Timing: For non-valvular atrial fibrillation
Side Effects: Bleeding, anemia
Heparin
Class: Unfractionated anticoagulant
Dosage: 60 units/kg IV bolus, then 12 units/kg/h infusion
Timing: Acute management if indicated
Side Effects: Thrombocytopenia, bleeding
Atorvastatin
Class: HMG-CoA reductase inhibitor
Dosage: 40–80 mg nightly
Timing: Start immediately for LDL-lowering
Side Effects: Myalgia, liver enzyme elevation
Simvastatin
Class: Statin
Dosage: 20–40 mg nightly
Timing: Secondary prevention
Side Effects: Muscle pain, GI upset
Lisinopril
Class: ACE inhibitor
Dosage: 10–40 mg daily
Timing: For blood pressure control
Side Effects: Cough, hyperkalemia
Losartan
Class: ARB
Dosage: 50–100 mg daily
Timing: Alternative for hypertension
Side Effects: Dizziness, increased potassium
Metoprolol
Class: Beta-blocker
Dosage: 50–100 mg twice daily
Timing: For heart rate and BP control
Side Effects: Fatigue, bradycardia
Insulin
Class: Antihyperglycemic
Dosage: Tailored to glucose levels
Timing: Acute management of hyperglycemia
Side Effects: Hypoglycemia
Citicoline
Class: Neuroprotective agent
Dosage: 500–2000 mg daily PO or IV
Timing: Early post-stroke
Side Effects: GI upset, insomnia
Levetiracetam
Class: Antiepileptic
Dosage: 500–1500 mg twice daily
Timing: If seizures occur
Side Effects: Somnolence, irritability
Baclofen
Class: GABA_B agonist
Dosage: 5 mg three times daily, titrate
Timing: For spasticity
Side Effects: Weakness, drowsiness
Tizanidine
Class: α₂-agonist
Dosage: 2 mg up to every 6 h PRN
Timing: Spasticity management
Side Effects: Dry mouth, hypotension
Paracetamol (Acetaminophen)
Class: Analgesic/antipyretic
Dosage: 500–1000 mg every 6 h PRN
Timing: Headache or pain relief
Side Effects: Rare — liver toxicity
Fluoxetine
Class: SSRI
Dosage: 20 mg daily
Timing: May aid motor recovery
Side Effects: Nausea, insomnia
Dietary Molecular Supplements
Omega-3 Fatty Acids (Fish Oil)
Dosage: 1–2 g EPA/DHA daily
Function: Anti-inflammatory, endothelial protection
Mechanism: Reduces platelet aggregation and vascular inflammation
Vitamin D₃ (Cholecalciferol)
Dosage: 2000 IU daily
Function: Neurosteroid support, bone health
Mechanism: Modulates neuronal survival and calcium homeostasis
Vitamin B₁₂ (Cobalamin)
Dosage: 1000 µg IM weekly for deficiency
Function: Myelin maintenance, neurotransmitter synthesis
Mechanism: Cofactor in methylation and nerve repair
Folate (Vitamin B₉)
Dosage: 400–800 µg daily
Function: Homocysteine reduction, DNA repair
Mechanism: Lowers homocysteine, protecting vascular endothelium
Magnesium Citrate
Dosage: 200–400 mg daily
Function: Neuroprotection, vasodilation
Mechanism: NMDA antagonist, reduces excitotoxicity
Coenzyme Q₁₀
Dosage: 100–200 mg daily
Function: Mitochondrial support
Mechanism: Enhances ATP production and antioxidant defenses
Curcumin
Dosage: 500 mg twice daily
Function: Anti-inflammatory, neuroprotective
Mechanism: Inhibits NF-κB, reduces oxidative stress
Resveratrol
Dosage: 150–500 mg daily
Function: Vascular health, antioxidant
Mechanism: Activates SIRT1, improves endothelial function
Alpha-Lipoic Acid
Dosage: 300–600 mg daily
Function: Free-radical scavenger
Mechanism: Regenerates other antioxidants, supports mitochondria
N-Acetylcysteine (NAC)
Dosage: 600 mg twice daily
Function: Glutathione precursor
Mechanism: Boosts intracellular antioxidant capacity
Advanced Regenerative & Specialty Agents
Alendronate (Bisphosphonate)
Dosage: 70 mg weekly
Function: Bone protection in immobilized patients
Mechanism: Inhibits osteoclasts, preventing bone loss
Denosumab (RANKL Inhibitor)
Dosage: 60 mg subcutaneously every 6 months
Function: Alternative to bisphosphonates
Mechanism: Prevents osteoclast formation and activity
Erythropoietin-Beta (Recombinant EPO)
Dosage: 40,000 IU subcutaneously weekly
Function: Neuroregeneration support
Mechanism: Promotes neurogenesis and angiogenesis
Filgrastim (G-CSF)
Dosage: 5 µg/kg/day subcutaneously for 5 days
Function: Mobilize bone-marrow stem cells
Mechanism: Stimulates proliferation and release of progenitor cells
Hyaluronic Acid (Viscosupplementation)
Dosage: Intra-articular injection as needed (not directly for stroke)
Function: Joint comfort in paretic limbs
Mechanism: Restores synovial fluid viscosity, reducing pain
Platelet-Rich Plasma (PRP)
Dosage: Autologous injection in targeted muscles/joints
Function: Deliver growth factors locally
Mechanism: Releases PDGF, TGF-β to support tissue repair
MultiStem® (Allogeneic MSC Therapy)
Dosage: Investigational IV infusion, variable dosing
Function: Promote neural repair
Mechanism: MSCs modulate inflammation and secrete trophic factors
Prochymal® (Mesenchymal Stem Cells)
Dosage: Investigational, repeated IV doses
Function: Immunomodulation, neuroprotection
Mechanism: Release anti-inflammatory cytokines, support angiogenesis
Tissue Plasminogen Activator Nanoparticles
Dosage: Experimental delivery systems under study
Function: Targeted thrombolysis
Mechanism: Nano-carrier improves clot penetration
Neurotrophic Growth Factor Cocktail
Dosage: Experimental infusions in clinical trials
Function: Enhance neuronal survival and sprouting
Mechanism: Combined BDNF, NGF, and GDNF to support repair
Surgical Interventions
Mechanical Thrombectomy
Procedure: Endovascular removal of clot via stent retriever.
Benefits: Rapid reperfusion, improved outcomes if ≤ 6–24 h window.
Decompressive Hemicraniectomy
Procedure: Removing part of skull to relieve intracranial pressure.
Benefits: Reduces fatal brain swelling in malignant infarction.
Carotid Endarterectomy
Procedure: Surgical removal of atherosclerotic plaque from carotid artery.
Benefits: Lowers risk of future strokes in high-grade stenosis.
Carotid Artery Stenting
Procedure: Angioplasty and stent placement in carotid artery.
Benefits: Alternative in patients unfit for endarterectomy.
Posterior Fossa Decompression
Procedure: Surgical widening of posterior fossa for large infarcts.
Benefits: Prevents brainstem herniation and secondary injury.
External Ventricular Drain (EVD) Placement
Procedure: Catheter insertion to relieve hydrocephalus.
Benefits: Controls intracranial pressure, improves consciousness.
Intracranial Aneurysm Clipping
Procedure: Surgical clipping of aneurysm causing compressive midbrain lesion.
Benefits: Prevents rebleeding and mass effect.
Carotid-Carotid Crossover Bypass
Procedure: Bypass graft between carotid arteries in occlusive disease.
Benefits: Restores cerebral perfusion in critical stenosis.
Microsurgical Cavernoma Resection
Procedure: Removal of a cavernous malformation compressing the midbrain.
Benefits: Eliminates risk of hemorrhage and local mass effect.
Deep Brain Stimulation (DBS)
Procedure: Electrodes implanted in thalamus or subthalamic nucleus.
Benefits: May improve post-stroke movement disorders in trials.
Prevention Strategies
Control High Blood Pressure
Maintain systolic < 130 mmHg with diet, exercise, and medication.
Manage Diabetes
Keep HbA1c < 7% to reduce vascular complications.
Lower Cholesterol
Use statins to achieve LDL < 70 mg/dL in high-risk patients.
Antiplatelet Therapy
Aspirin or clopidogrel for those with prior ischemic events.
Anticoagulation for Atrial Fibrillation
DOACs or warfarin to maintain therapeutic INR or factor inhibition.
Smoking Cessation
Quit tobacco to improve endothelial function.
Healthy Diet
Emphasize fruits, vegetables, whole grains, and lean proteins.
Regular Exercise
≥ 150 minutes of moderate activity per week.
Weight Management
Maintain BMI 18.5–24.9 kg/m².
Limit Alcohol
≤ 1 drink/day for women, ≤ 2 drinks/day for men.
When to See a Doctor
Sudden eyelid drooping or double vision
Acute weakness or numbness on one side of face, arm, or leg
Difficulty speaking or understanding speech
Severe headache with no clear cause
Altered consciousness or confusion
Balance or coordination problems
New-onset seizures
Sudden vision loss in one eye
Severe nausea or vomiting with neurological signs
Rapid heart rhythm with other acute symptoms
In any of these situations, call emergency services immediately.
What to Do and What to Avoid
Do:
Call emergency services at first signs.
Note exact time of symptom onset.
Keep the person calm and lying flat if possible.
Monitor airway, breathing, and circulation.
Keep NPO (nil per os) until swallow function assessed.
Provide supplemental oxygen if needed.
Prepare medication list for EMS/ER.
Encourage family or witness to report medical history.
Elevate head of bed slightly after acute period.
Engage in early rehabilitation once stable.
Avoid:
Do not give aspirin until hemorrhage is excluded by CT.
Avoid rapid BP lowering—target gradual reduction.
Do not feed or give fluids until swallow assessment.
Avoid sedatives that may mask neurological status.
Do not allow the patient to walk unassisted.
Avoid dehydration—maintain IV fluids as ordered.
Do not ignore new seizures—report immediately.
Avoid excessive neck movements or traction.
Do not resume anticoagulants until hemorrhage ruled out.
Avoid unsupported risk-taking behaviors during recovery.
Frequently Asked Questions
What causes Weber’s syndrome?
Occlusion of a small artery branch—often from the posterior cerebral artery—leading to a midbrain infarction that damages oculomotor fibers and corticospinal tracts.How common is Weber’s syndrome?
It is rare, representing a small fraction of all brainstem strokes, but exact incidence is not well established.What are the first signs of Weber’s syndrome?
Sudden drooping of one eyelid, double vision, and weakness on the opposite side of the body.Can Weber’s syndrome affect both sides?
It typically affects only one side because the arterial occlusion is unilateral.Is the pupil always dilated?
Yes—damage to the parasympathetic fibers in the oculomotor nerve causes a “fixed, dilated pupil.”What is the role of clot-busting drugs?
Intravenous thrombolytics (e.g., alteplase) can dissolve the clot if given within 4.5 hours of symptom onset to improve recovery.How soon should I start rehabilitation?
Early mobilization and therapy, ideally within 24–48 hours after stabilization, improve long-term outcomes.Is surgery always needed?
Most patients do not require surgery unless there is life-threatening swelling, hydrocephalus, or an underlying structural lesion.What is the recovery outlook?
Prognosis varies; early treatment, younger age, and fewer comorbidities predict better functional recovery.Can Weber’s syndrome recur?
If underlying risk factors (e.g., hypertension, atrial fibrillation) are uncontrolled, recurrent stroke is possible.Are there genetic factors?
Unlike Sturge-Weber syndrome, classic Weber’s syndrome is not genetic but vascular in origin.Will vision return to normal?
Partial improvement of oculomotor function can occur, but some patients may have persistent eyelid droop or eye alignment issues.What specialists are involved?
Neurologists, interventional neuroradiologists, physiatrists, and physical/occupational therapists collaborate on care.Are there any experimental treatments?
Stem cell therapies and neurotrophic factor cocktails are under investigation but not yet standard of care.How can I prevent future strokes?
Control blood pressure, cholesterol, diabetes, quit smoking, exercise regularly, and adhere to prescribed antiplatelet or anticoagulant medications.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: July 08, 2025.
